相似文献
1
A role for Streptococcus pneumoniae in virus-associated pneumonia.
Nat Med. 2004 Aug;10(8):811-3. doi: 10.1038/nm1077. Epub 2004 Jul 11.
2
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
N Engl J Med. 2003 Oct 2;349(14):1341-8. doi: 10.1056/NEJMoa035060.
3
Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa.
J Infect Dis. 2015 Oct 1;212(7):1082-92. doi: 10.1093/infdis/jiv167. Epub 2015 Mar 17.
4
The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.
Hum Vaccin Immunother. 2016;12(2):314-25. doi: 10.1080/21645515.2015.1084450.
5
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
Pediatr Infect Dis J. 2012 Jan;31(1):72-7. doi: 10.1097/INF.0b013e318233049d.
6
Passive immunization for the prevention of otitis media.
Vaccine. 2000 Dec 8;19 Suppl 1:S116-21. doi: 10.1016/s0264-410x(00)00289-9.
7
Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
BMC Infect Dis. 2019 Jul 10;19(1):605. doi: 10.1186/s12879-019-4254-2.
8
9
IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24.
10
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
Vaccine. 2013 Aug 2;31(35):3577-84. doi: 10.1016/j.vaccine.2013.04.085. Epub 2013 May 18.
引用本文的文献
1
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities.
Curr Opin Infect Dis. 2025 Oct 1;38(5):468-476. doi: 10.1097/QCO.0000000000001126. Epub 2025 Aug 6.
2
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.
PLoS One. 2025 Jul 1;20(7):e0325149. doi: 10.1371/journal.pone.0325149. eCollection 2025.
3
Temporal Changes in Nasopharyngeal Pneumococcal Colonization Density Associated With Respiratory Syncytial Virus and Influenza in a South African Household Cohort Study, 2016-2018.
Open Forum Infect Dis. 2025 May 31;12(6):ofaf267. doi: 10.1093/ofid/ofaf267. eCollection 2025 Jun.
4
Epidemiology and Mortality Risk of Severe Viral Pneumonia During the Pre-Pandemic, COVID-19 Pandemic and Post-Pandemic Era: A Retrospective Study of Hospitalized Children in ShenZhen, China Between 2017 and 2023.
J Epidemiol Glob Health. 2025 Apr 3;15(1):53. doi: 10.1007/s44197-025-00398-7.
5
Incidence of pneumococcal disease in children in Germany, 2014-2019: a retrospective cohort study.
BMC Pediatr. 2024 Nov 20;24(1):755. doi: 10.1186/s12887-024-05003-7.
6
Lipopolysaccharide as a Vaccine Target and the Role of Antibodies in Protection from Disease.
Vaccines (Basel). 2024 Oct 17;12(10):1177. doi: 10.3390/vaccines12101177.
7
Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia.
J Clin Invest. 2024 Sep 10;134(21):e180986. doi: 10.1172/JCI180986.
8
Increased risk of bacterial pneumonia before and after respiratory syncytial virus infection in young children.
Acta Paediatr. 2025 Jan;114(1):83-91. doi: 10.1111/apa.17405. Epub 2024 Aug 28.
9
Association of Pneumococcal Conjugate Vaccination With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Older Adult Recipients of Coronavirus Disease 2019 Vaccines: A Longitudinal Cohort Study.
J Infect Dis. 2024 Nov 15;230(5):e1082-e1091. doi: 10.1093/infdis/jiae387.
10
Bacterium-like Particles from as Mucosal Adjuvant for the Development of Pneumococcal Vaccines.
Vaccines (Basel). 2024 Apr 12;12(4):412. doi: 10.3390/vaccines12040412.
本文引用的文献
1
Respiratory viruses predisposing to bacterial infections: role of neuraminidase.
Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S87-97. doi: 10.1097/01.inf.0000108197.81270.35.
2
Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants.
Clin Infect Dis. 2003 Dec 15;37(12):1705-10. doi: 10.1086/379771. Epub 2003 Nov 19.
3
Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells.
J Infect Dis. 2003 Dec 15;188(12):1928-39. doi: 10.1086/379833. Epub 2003 Dec 3.
4
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
N Engl J Med. 2003 Oct 2;349(14):1341-8. doi: 10.1056/NEJMoa035060.
5
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
N Engl J Med. 2003 May 1;348(18):1737-46. doi: 10.1056/NEJMoa022823.
6
Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
Clin Infect Dis. 2002 Nov 1;35(9):1120-6. doi: 10.1086/343049. Epub 2002 Oct 7.
7
Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.
Pediatr Infect Dis J. 2001 Oct;20(10):951-8. doi: 10.1097/00006454-200110000-00008.
8
Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children.
Pediatr Infect Dis J. 2000 Dec;19(12):1141-7. doi: 10.1097/00006454-200012000-00004.
9
Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1.
J Pediatr. 2000 Jul;137(1):78-84. doi: 10.1067/mpd.2000.105350.
10
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
Pediatr Infect Dis J. 2000 Mar;19(3):187-95. doi: 10.1097/00006454-200003000-00003.
Zotero 插件